Pfizer Inc. (PFE) vs Sanofi (SNY)
- Pfizer Inc. PFE 29.58 +0.48%
- Sanofi SNY 40.61 +0.79%
Pfizer Inc. and Sanofi are both Drug Manufacturers General companies. Pfizer Inc. is the larger, with a market value of $167.8B against $96.0B — 1.7× the size. Sanofi trades at the lower P/E: 21.3× against 38.9×. Sanofi grew revenue faster over the last twelve months: 21.3% against −0.21%. Sanofi has the higher net margin (8.22% vs 6.80%) and the higher return on invested capital (6.58% vs 6.30%). Both pay a dividend; Sanofi yields more (5.97% vs 5.81%). Across the 23 metrics below, Sanofi leads on 17 and Pfizer Inc. on 6.
Valuation
Profitability
| Metric | PFE | SNY | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 73.18% | 72.78% | 72.77% |
| Operating margin | 21.70% | 18.24% | 18.77% |
| Net margin | 6.80% | 8.22% | 8.27% |
| Free cash flow margin | 17.25% | 25.53% | 17.18% |
| Return on equity | 4.97% | 5.87% | 5.87% |
| Return on assets | 2.13% | 3.21% | 2.57% |
| Return on invested capital | 6.30% | 6.58% | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack